Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LNSR US Equity

LENSAR, Inc.Health Care · Surgical & Medical Instruments & Apparatus · CIK 1320350 · FY ends Dec 31
$8.72
+0.53 (+6.47%)
USD · as of 2026-08-19 · marketstack
4 registered studies · 0 active

Studies where LNSR is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

3 interventional · 1 observational

Held by 7 tracked-famous managers (MILLENNIUM MANAGEMENT LLC, Man Group plc, GABELLI FUNDS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, +2 more) · FINRA short interest 12.2 days to cover (settled 2026-07-31) · government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Retrospective Analysis of the Time Elements for Different Workflow Scenarios During Femtosecond Laser-assisted Cataract Surgery (FLACS) From the Surgeon, Staff, and Patient Perspectives.NCT07038395observationalIdentification of the amount of time in seconds required to perform surgical actions relevant to the FLACS procedureCompletedDevice: workflowCataract462024-05-17actual2025-06-26
Feasibility Study of Laser Treatment of the Crystalline Lens to Correct PresbyopiaNCT01062412Increased objective amplitude of accommodationNon-randomized · Open-label · TreatmentNot applicableTerminatedsponsor's stated reason: No improvement in near vision was detectedDevice: LensAR Laser SystemPresbyopia, Cataract802011-10-04actual2022-03-21
Prospective Clinical Trial of the LensAR Laser SystemNCT01014702Completeness and ease of opening of capsulotomyNon-randomized · Open-label · TreatmentPhase 2/3Unknown statusDevice: LensAR Laser System, Conventional phacoemulsificationCataract100Jun 20112011-04-15
Laser Treatment of the Crystalline LensNCT01001117Capsulotomy a. Ease of opening b. Achievement of intended shape and sizeNon-randomized · Open-label · TreatmentPhase 2/3Unknown statusDevice: LensAR laser surgery, Phaco-emulsification cataract surgeryCataract75Oct 2009actual2011-04-15

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19